H. Howard
Feb 1, 2007
Citations
0
Influential Citations
1
Citations
Journal
Expert Opinion on Therapeutic Patents
Abstract
A novel series of 4-arylpiperidines and their salts, as well as their use in the treatment of CNS disorders, that is, depression, are disclosed. These compounds function as serotonin transporter (SERT) inhibitors and demonstrate significant activity and selectivity for SERT versus other receptors and monoamine transporters.